Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

DRAX EXAMETAZIME

TECHNETIUM TC-99M EXAMETAZIME KIT

Standard Dose
N/A
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DRAX EXAMETAZIME is listed in Drugs@FDA under application 208870 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TECHNETIUM TC-99M EXAMETAZIME KIT Form and strength POWDER;INTRAVENOUS - N/A Sponsor JUBILANT Submission history Latest submission status date: 2017-08-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview DRAX EXAMETAZIME is listed in Drugs@FDA under application 208870 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TECHNETIUM TC-99M EXAMETAZIME KIT Form and strength POWDER;INTRAVENOUS - N/A Sponsor JUBILANT Submission history Latest submission status date: 2017-08-17 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
DRAX EXAMETAZIME (TECHNETIUM TC-99M EXAMETAZIME KIT) | Drug Monograph | MedicHelpline